Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression

Journal of Psychiatric Research - Tập 35 Số 2 - Trang 83-94 - 2001
Astrid Zobel1, Thomas Nickel2, Annette Sonntag2, Manfred Uhr3, Herta Flor4, Marcus Ising5
1Max Planck Institute of Psychiatry, Kraepelinstr. 2–10, 80804 Munich, Germany
2Max Planck Institute of Psychiatry, Max Planck Society
3AG Uhr, Manfred, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society
4Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society
5AG Ising, Marcus, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society

Tóm tắt

Từ khóa


Tài liệu tham khảo

Arndt, 2000, Correlating and predicting psychiatric symptom ratings: Spearman's r versus Kendall's tau correlation, Journal of Psychiatric Research, 33, 97, 10.1016/S0022-3956(98)90046-2

Brady, 1991, Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralcorticoid receptor gene expression in rat brain. Therapeutic implications, Journal of Clinical Investigation, 87, 831, 10.1172/JCI115086

Gotthard, 1995, Cortisol, ACTH, and cardiovascular response to a cognitive challenge paradigm in aging and depression, American Journal of Physiology, 268, R865

1976

Hamilton, 1976, A rating scale for depression, Journal of Neurology, Neurosurgery & Psychiatry, 23, 56, 10.1136/jnnp.23.1.56

Heuser, 1994, The combined dexamethasone-/CRH-test: a refined laboratory test for psychiatric disorder, Journal of Psychiatric Research, 28, 341, 10.1016/0022-3956(94)90017-5

Heuser, 1994, Age-associated changes of pituitary adrenocortical hormone regulation in humans: importance of gender, Neurobiol. Aging, 15, 227, 10.1016/0197-4580(94)90117-1

Heuser, 1996, Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects, American Journal of Psychiatry, 53, 93

Holsboer F. Neuroendocrinology of mood disorders. In: Bloom FE, Kupfer DJ, editor. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995: 957–69.

Holsboer, 1999, The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety, Journal of Psychiatry Research, 33, 181, 10.1016/S0022-3956(98)90056-5

Holsboer, 2000, The corticosteroid receptor hypothesis of depression, Neuropsychopharmacology, 23, 477, 10.1016/S0893-133X(00)00159-7

Holsboer, 1996, Antidepressants and hypothalamic-pituitary-adrenocortical regulation, Endocrine Reviews, 17, 187, 10.1210/edrv-17-2-187

Holsboer, 1992, The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia, Progress in Brain Research, 93, 385, 10.1016/S0079-6123(08)64586-0

Holsboer, 1987, Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression, Biological Psychiatry, 22, 228, 10.1016/0006-3223(87)90237-X

Holsboer-Trachsler, 1991, Repeated administration of the combined dexamethasone — human corticotropin releasing hormone stimulation test during treatment of depression, Psychiatry Research, 38, 163, 10.1016/0165-1781(91)90041-M

Holsboer-Trachsler, 1994, Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment — neurobiological and psychometric assessment of course, Journal of Psychiatric Research, 28, 381, 10.1016/0022-3956(94)90020-5

Kessing, 1998, Recurrence in affective disorder II — effect of age and gender, British Journal of Psychiatry, 172, 29, 10.1192/bjp.172.1.29

Kessing, 2000, Predictors of recurrence in affective disorder — analyses accounting for individual heterogeneity, Journal of Affective Disorders, 57, 139, 10.1016/S0165-0327(99)00080-4

Meijer, 1998, Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice, Endocrinology, 139, 1789, 10.1210/en.139.4.1789

Montgomery, 1979, A new depression scale designed to be sensitive to change, Journal of Psychiatry, 134, 382, 10.1192/bjp.134.4.382

Montkowski, 1995, Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function, Journal of Neuroendocrinology, 7, 841, 10.1111/j.1365-2826.1995.tb00724.x

Mori, 1998, cAMP-dependent phosphorylation system after short- and long-term administration of moclobemide, Journal of Psychiatric Research, 32, 111, 10.1016/S0022-3956(98)00003-X

Oshima, 2001, Psychological, autonomic, and neuroendocrine responses to acute stressors in the combined dexamethasone/CRH test: a study in healthy subjects, Journal of Psychiatric Research, 35, 10.1016/S0022-3956(01)00010-3

Owens, 1991, Physiology and pharmacology of corticotropin-releasing factor, Pharmacology Review, 43, 425

Reul, 1993, Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system, Endocrinology, 133, 312, 10.1210/en.133.1.312

Reul, 1994, Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase — an inhibitor moclobemide, Neuroendocrinology, 60, 509, 10.1159/000126788

Rybakowski, 1999, The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness, Journal of Psychiatric Research, 33, 363, 10.1016/S0022-3956(99)00014-X

Seckl, 1992, Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo, Neuroendocrinology, 55, 621, 10.1159/000126180

Seeman, 1995, Gender differences in patterns of HPA axis response to challenge: MacArthur studies of successful aging, Psychoneuroendocrinology, 20, 711, 10.1016/0306-4530(95)00024-0

Vedder, 1999, Regulation of glucocorticoid receptor-mRNA in human blood cells by amitriptyline and dexamethasone, Journal of Psychiatric Research, 33, 303, 10.1016/S0022-3956(99)00006-0

von Bardeleben, 1989, Cortisol response to a combined dexamethasone — human corticotropin-releasing hormone challenge in patients with depression, Journal of Neuroendocrinology, 1, 485, 10.1111/j.1365-2826.1989.tb00150.x

von Bardeleben, 1991, Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone, Biological Psychiatry, 29, 1042, 10.1016/0006-3223(91)90360-X

von Bardeleben, 1985, Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects, Life Sciences, 37, 1613, 10.1016/0024-3205(85)90480-1

von Bardeleben, 1988, Exaggerated corticotrophic cell response to human corticotropin-releasing hormone in two patients during long-term carbamazepine treatment, Biological Psychiatry, 24, 331, 10.1016/0006-3223(88)90202-8

von Eye, 1999

Zobel, 2000, Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated, Journal of Psychiatric Research, 34, 171, 10.1016/S0022-3956(00)00016-9

Zobel, 1999, Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression, American Journal of Psychiatry, 156, 949, 10.1176/ajp.156.6.949